BioNTech SE American Depositary Share

BNTX
$92.50 +1.04 (1.14%)
Payout Frequency

Dividend History

Pay DateAmountEx-DateRecord Date
June 17, 2022$2.132022-06-022022-06-03

Dividends Summary

Company News

Nanobiotechnology Market to Hit USD 420.2 Billion by 2034, Fueled by 2025 Traffic Growth and Strategic Material & Product Innovations
GlobeNewswire Inc. • Towards Healthcare • December 17, 2025

The global nanobiotechnology market is projected to grow from USD 172.81 billion in 2024 to USD 420.2 billion by 2034, driven by healthcare demand, R&D funding, and technological innovations in drug delivery and medical applications.

Pfizer Sees Slower 2026 Growth Despite Pipeline Push, Cost Cuts
Benzinga • Vandana Singh • December 16, 2025

Pfizer forecasts lower 2026 earnings and sales, anticipating reduced COVID-19 product revenues and product patent losses, while maintaining focus on R&D and cost management strategies.

2 Top Dividend Stocks to Buy and Hold
The Motley Fool • Prosper Junior Bakiny • November 30, 2025

The article highlights Bristol Myers Squibb and Johnson & Johnson as attractive dividend stocks, despite facing challenges like patent cliffs and legal issues. Both companies demonstrate resilience through innovative product launches and consistent dividend growth.

Private-Public Deal Momentum Grows, Yet Megamergers Stay Elusive
Investing.com • Christine Short • June 18, 2025

While smaller deals have been completed, including overseas acquisitions, the expected surge in large-scale mergers and acquisitions has not materialized. Factors like trade policy uncertainty and economic concerns have kept corporate decision-makers cautious about striking major deals.

Pfizer (PFE) Q2 Earnings Coming Up: What Should Investors Do? - Zacks Investment Research
Zacks Investment Research • N/A • July 24, 2024

Pfizer is expected to report Q2 2024 earnings on July 30, with consensus estimates of $13.22 billion in sales and $0.45 per share. While COVID-19 product sales are expected to decline, key non-COVID drugs like Prevnar, Vyndaqel, and Eliquis are likely to provide top-line support. The company's recent acquisitions and new product launches are also...

Related Companies